BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19563827)

  • 1. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenetics of depression in elderly patients].
    Monnin J; Haffen E; Sechter D; Vandel P
    Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and antidepressant drugs.
    Binder EB; Holsboer F
    Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HTTLPR modulates antidepressant efficacy in depressed women.
    Gressier F; Bouaziz E; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Psychiatr Genet; 2009 Aug; 19(4):195-200. PubMed ID: 19451862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics of mood disorders: what clinicians need to know.
    Laje G
    CNS Spectr; 2013 Oct; 18(5):272-84. PubMed ID: 24050155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 14. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
    Steimer W
    Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics/pharmacogenomics in psychiatry].
    Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
    Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].
    Baumann P
    Encephale; 1986; 12(4):143-8. PubMed ID: 3792273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent molecular genetic studies and methodological issues in suicide research.
    Tsai SJ; Hong CJ; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):809-17. PubMed ID: 20977922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressive treatment.
    Zobel A; Maier W
    Eur Arch Psychiatry Clin Neurosci; 2010 Aug; 260(5):407-17. PubMed ID: 20047055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
    Perroud N; Bondolfi G; Uher R; Gex-Fabry M; Aubry JM; Bertschy G; Malafosse A; Kosel M
    Pharmacogenomics; 2011 Mar; 12(3):365-77. PubMed ID: 21449676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.